Status:
RECRUITING
Effect of Albumin Replacement on Oxygen Delivery in Sepsis Patients
Lead Sponsor:
Samsun University
Conditions:
Sepsis
Intensive Care Unit
Eligibility:
All Genders
18+ years
Brief Summary
Fluid resuscitation is a critical component of sepsis treatment. Research has shown that intravenous (IV) fluid therapy in sepsis positively impacts cardiac output and thereby oxygen (O2) delivery thr...
Detailed Description
Patients will be admitted from the emergency room, operating room or medical wards. After obtaining written consent from the patients or their guardians, patients who are followed up in the intensive ...
Eligibility Criteria
Inclusion
- Followed up with a diagnosis of sepsis,
- over 18 years old
- Patients who were diagnosed with hypo-albuminemia after more than 4L/day fluid resuscitation and underwent albumin replacement
Exclusion
- Consent is not given by the patient or his/her guardian,
- The initial cause of shock was hypovolemic, cardiogenic or obstructive shock.
- Pregnancy or suspected pregnancy
- Peripheral limb or severe organ ischemia with peripheral artery disease
- Cardiac functions cannot be evaluated optimally by transthoracic echocardiography
- Patients who died within the first 24 hours after intensive care admission
Key Trial Info
Start Date :
November 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06556914
Start Date
November 15 2024
End Date
October 15 2025
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsun University
Samsun, Ilkadım, Turkey (Türkiye), 55100